TITLE

COMMENTARY: Fondaparinux was as effective as (noninferior to) enoxaparin in acute symptomatic deep venous thrombosis

AUTHOR(S)
Crowther, Mark
PUB. DATE
November 2004
SOURCE
ACP Journal Club;Nov/Dec2004, Vol. 141 Issue 3, p74
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
The article presents a commentary on the study, which concluded that fondaparinux was as effective as (noninferior to) enoxaparin in acute symptomatic deep venous thrombosis (DVT). The article adds that although heparin-induced thrombocytopenia (HIT) is rare in patients treated with LMWH, the risk for HIT should be further reduced in patients treated with fondaparinux. Finally, fondaparinux is synthetic, unlike other heparins, which are derived from animal tissues. The choice of which medication to use in patients with DVT should be based on such issues as convenience, cost, familiarity, and local availability.
ACCESSION #
15303599

 

Related Articles

  • Fondaparinux was as effective as (noninferior to) enoxaparin in acute symptomatic deep venous thrombosis.  // ACP Journal Club;Nov/Dec2004, Vol. 141 Issue 3, p74 

    The article addresses the question whether fondaparinux is as effective as (noninferior to) enoxaparin for reducing symptomatic recurrent venous thromboembolic complications, major bleeding, or all-cause mortality in patients with acute symptomatic deep venous thrombosis (DVT). The article...

  • Does intermittent pneumatic compression reduce the risk of post stroke deep vein thrombosis? The CLOTS 3 trial: statistical analysis plan. Dennis, Martin; Sandercock, Peter; Murray, Gordon; Forbes, John // Trials;2013, Vol. 14 Issue 1, p1 

    Background: Venous thromboembolism (VTE) is a common and important complication of stroke. The CLOTS 3 trial aims to determine whether, compared with best medical care, best medical care plus intermittent pneumatic compression (IPC) in immobile stroke patients reduces the risk of proximal deep...

  • Review: Several factors are associated with the performance of D-dimer assays for detecting deep venous thrombosis.  // ACP Journal Club;Nov/Dec2004, Vol. 141 Issue 3, p76 

    The article addresses the question as to which factors are associated with the performance of D-dimer assays for detecting lower-extremity deep venous thrombosis (DVT) in symptomatic patients. The article adds that in symptomatic patients, biochemical and technical characteristics of the assays,...

  • The risk of recurrent venous thromboembolism: The Austrian Study on Recurrent Venous Thromboembolism. Kyrle, Paul Alexander; Eichinger, Sabine // Wiener Klinische Wochenschrift;2003, Vol. 115 Issue 13/14, p471 

    Venous thromboembolism (VTE) is a chronic disease. After withdrawal of oral anticoagulation at least a third of patients will experience a subsequent episode of venous thrombosis. Of these patients, approximately 5% will die from pulmonary embolism. The Austrian Study on Recurrent Venous...

  • Commentary. Stevens, Scott M.; Ageno, Walter // Evidence Based Medicine;Apr2006, Vol. 11 Issue 2, p56 

    The article presents a comment on the study on the detection of presence or absence of deep vein thrombosis by using individual clinical features, structured risk scores and physicians' empirical judgments. DVT has non-specific clinical presentation. D-dimer, a breakdown product of fibrin, is...

  • Compression Stockings and Post-Thrombotic Syndrome. Shaughnessy, Allen F. // American Family Physician;1/1/2005, Vol. 71 Issue 1, p144 

    Deals with whether off-the-shelf compression stockings can prevent post-thrombotic syndrome in patients with a proximal deep venous thrombosis. Patients who were diagnosed with mild post-thrombotic syndrome in the study; List of post-thrombotic symptoms.

  • Molecular Diagnostics of Inherited Thrombosis. League, Stacy; Hooper, W. Craig // Clinical Laboratory Science;Fall2005, Vol. 18 Issue 4, p271 

    Thrombophilia can best be defined as a disorder of coagulation that contributes to a predisposition towards thrombosis. Although the term thrombophilia has been used to describe arterial thrombosis, its most common usage has been in reference to venous thromboembolism (VTE). Thrombophilia can be...

  • Genetic variations in sites of affinity between FVIII and LRP1 are not associated with high FVIII levels in venous thromboembolism. Bittar, Luis F.; Siqueira, Lucia H.; Orsi, Fernanda A.; De Paula, Erich V.; Annichino-Bizzacchi, Joyce M. // Scientific Reports;3/20/2015, p9246 

    Increased factor VIII (FVIII) levels are a prevalent and independent risk factor for venous thromboembolism (VTE). The low density lipoprotein receptor-related protein 1 (LRP1) has been associated with FVIII catabolism. After a median of 10 years of the first thrombotic episode, we evaluated...

  • COMMENTARY: Several factors are associated with the performance of D-dimer assays for detecting deep venous thrombosis. Perrier, Arnaud // ACP Journal Club;Nov/Dec2004, Vol. 141 Issue 3, p76 

    The article presents a commentary on the study, which concluded that several factors are associated with the performance of D-dimer assays for detecting deep venous thrombosis. Plasma D-dimer is emerging as a simple biological test that may rule out proximal DVT in selected patients. The most...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics